WOBURN, Mass., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company will host a conference call and live webcast on Thursday, January 26th to provide investors with a presentation on the highlights of the 2016 Camelina Field Test results for the C3003 yield trait. Yield10 is focusing on developing disruptive technologies for step-change improvements to crop yield to enhance global food security.
Conference Call Information
Management will host the investor presentation conference call on Thursday, January 26th, 2017 at 4:30 p.m. (ET). A live webcast of the call, including the slide deck, can be accessed on the Company website at http://www.yield10bio.com in the investor relations section. To participate in the call, dial toll-free 877-709-8150 or 201-689-8354 (international).
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13653574. The replay will be available for 14
days. In addition, the webcast will be archived on the Company's website in the investor relations section.
About Yield10
Yield10 Bioscience, Inc. is focused on developing disruptive technologies for producing step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA.
For more information about the company, please visit www.yield10bio.com.
(YTEN-G)
Yield10 Inquiries:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations Contact:
Amato and Partners, LLC90 Park Avenue, 17th Floor
New York, NY 10016
admin@amatoandpartners.com
Source:
Yield10 Bioscience, Inc.
News Provided by Acquire Media
